Biotech · Private company

TriSalus Life Sciences, Inc.

Track this companyFree. Adds TriSalus Life Sciences, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials127 recruiting or active

Pipeline programs10From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline10

IpilimumabPhase 2 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
NivolumabPhase 2 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
PembrolizumabPhase 2 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
SD-101Phase 2 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
anti-PD-1Phase 1 · Locally Advanced Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
IpilimumabPhase 1 · Metastatic Uveal Melanoma in the LiverClinicalTrials.gov · fetched Nov 12, 2026
NivolumabPhase 1 · Metastatic Uveal Melanoma in the LiverClinicalTrials.gov · fetched Nov 12, 2026
Nivolumab and RelatlimabPhase 1 · Metastatic Uveal Melanoma in the LiverClinicalTrials.gov · fetched Nov 12, 2026
SD-101Phase 1 · Locally Advanced Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
SD-101Phase 1 · Metastatic Uveal Melanoma in the LiverClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials12

End Hole vs. Pressure-Modulated Delivery of Y-90 Resin Microspheres to Liver Metastases.NA · NOT_YET_RECRUITING · started Nov 1, 2026ClinicalTrials.gov NCT07791446 · fetched Nov 12, 2026
PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion SystemNA · RECRUITING · started Aug 1, 2026ClinicalTrials.gov NCT07444645 · fetched Nov 12, 2026
Pressure-enabled Retrograde Occlusive Therapy With Embolization for Control of Thyroid Disease (PROTECT Registry): A Multicenter RegistryENROLLING_BY_INVITATION · started Apr 1, 2025ClinicalTrials.gov NCT06868459 · fetched Nov 12, 2026
Cryoablation and Arterial Infusion of SD-101 in Combination With Durvalumab and TremelimumabPHASE1 · ACTIVE_NOT_RECRUITING · started Jan 3, 2025ClinicalTrials.gov NCT06710223 · fetched Nov 12, 2026
Lipiodol Deposition Using Endhole vs. Pressure-Modulated DeliveryNA · ACTIVE_NOT_RECRUITING · started Feb 1, 2024ClinicalTrials.gov NCT06204159 · fetched Nov 12, 2026
TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment PlanningNA · ACTIVE_NOT_RECRUITING · started Mar 14, 2023ClinicalTrials.gov NCT05743842 · fetched Nov 12, 2026
Pressure Enabled Intrapancreatic Delivery of SD-101 With Checkpoint Blockade for Locally Advanced Pancreatic AdenocarcinomaPHASE1 · ACTIVE_NOT_RECRUITING · started Mar 1, 2023ClinicalTrials.gov NCT05607953 · fetched Nov 12, 2026
Pain Reduction and Ovarian Perfusion Following Uterine Fibroid EmbolizationNA · TERMINATED · started Feb 9, 2023ClinicalTrials.gov NCT06106633 · fetched Nov 12, 2026
Pressure Enabled Delivery of SD-101 With Checkpoint Blockade for Primary Liver TumorsPHASE1_PHASE2 · TERMINATED · started Mar 2, 2022ClinicalTrials.gov NCT05220722 · fetched Nov 12, 2026
Pressure-enabled Delivery in Radioembolization (TriNav Study)NA · COMPLETED · started Mar 1, 2022ClinicalTrials.gov NCT05128032 · fetched Nov 12, 2026
Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal MelanomaPHASE1 · TERMINATED · started Aug 2, 2021ClinicalTrials.gov NCT04935229 · fetched Nov 12, 2026
Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADTPHASE2 · COMPLETED · started May 17, 2017ClinicalTrials.gov NCT03007732 · fetched Nov 12, 2026